Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Polycystic ovary syndrome (PCOS) is the most common female endocrine disorder with unknown etiology and with different complications. The aim of this study was to evaluate the effect of omega-3 supplementation on PCOS symptoms and metabolic syndrome. Materials and Methods: This double-blind clinical trial was performed in 2015 in Alzahra and Shahid Beheshti Hospitals, Isfahan, Iran, on 88 patients with PCOS. Intervention group took omega-3 supplements with dose of 2 g/day for 6 months (two capsules), but control group received two olive oil capsules. Finally, ultrasound and laboratory findings and the recovery rate of menstrual disorders in both groups were compared. Results: After 6 months’ intervention, waist circumference (WC) was significantly lower in omega-3 as compared to control (81.18 ± 2.87 vs. 84.22 ± 2.61 cm, respectively, P < 0.0001). High-density lipoprotein was increased (47.2 ± 1.37 vs. 41.56 ± 1.34 mg/dl, respectively, P < 0.0001) while low-density lipoprotein (107.79 ± 1.68 vs. 117.4 ± 1.57 mg/dl, respectively), triglyceride (116.02 ± 3.13 vs. 125.06 ± 2.91 mg/dl, respectively), and cholesterol (180.34 ± 6.34 vs. 189.56 ± 5.93 mg/dl, respectively) in omega-3 were significantly lower than control (P < 0.0001). The interval between periods in omega-3 was significantly shorter than control (29.83 ± 4.68 vs. 47.11 ± 8.72 days, respectively, P < 0.001). Conclusion: Omega-3 decrease lipid profiles, WC, and interval between periods while weight, hip circumference, fasting blood sugar, number of ovarian follicle, size of ovary, bleeding volume, menstrual bleeding, and hirsutism score did not change by administration of omega-3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus
Ovalle, F., & Azziz, R. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03111-4 · Cited by 428 · cited 1×
“Journal of Research in Medical Sciences | 2017 | 2 and infertility and metabolic disorders have evaluated as potential contributors.[9] Metabolic syndrome is more frequent in these patients than general population, and 33%–50% of US women with PCOS have metabolic syndrome compared with only 12% in a similarly aged in…”
BackgroundWoodman, R. J., Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F., & Beilin, L. J. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.1007 · Cited by 338 · cited 1×
“[17,19,22‐24] These findings show the effect of fish oil on TG levels in patients with PCOS, whereas it was shown that effect of fish oil on TG levels is dose dependent.[23] The effect of omega‐3 in patients with PCOS on other serum lipid values reported differently, some studies reported no significant differences in…”
Result
Research works printed but not linked: 21
- Baptiste, 2010, Insulin and hyperandrogenism in women with polycystic ovary syndrome, J Steroid Biochem Mol Biol, 122, 42, 10.1016/j.jsbmb.2009.12.010 · DOI · Paper page
- Kelley, 2014, Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome, stroenterol, 20, 14172
- González, 2013, Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome, Am J Physiol Endocrinol Metab, 304, E375, 10.1152/ajpendo.00491.2012 · DOI · Paper page
- Khani, 2011, Effect of soy phytoestrogen on metabolic and hormonal disturbance of women with polycystic ovary syndrome, J Res Med Sci, 16, 297
- Mehrabian, 2011, The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria, Endokrynol Pol, 62, 238
- Chittenden, 2009, Polycystic ovary syndrome and the risk of gynaecological cancer: A systematic review, Reprod Biomed Online, 19, 398, 10.1016/S1472-6483(10)60175-7 · DOI · Paper page
- Haji Shafiha, 2007, Investigating validity criteria of vaginal ultrasound (ovarian volume, the ovarian stroma and the stromal surface of the ovary) in the diagnosis of polycystic ovary syndrome, Urmia Med J, 3, 538
- Glueck, 2003, Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome, Metabolism, 52, 908, 10.1016/S0026-0495(03)00104-5 · DOI · Paper page
- Lo, 2006, Epidemiology And Adverse Cardiovascular Risk Profile Of Diagnosed Polycystic Ovary Syndrome, J Clin Endocrinol Metab, 91, 1357, 10.1210/jc.2005-2430 · DOI · Paper page
- Phelan, 2011, Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: Results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial, Am J Clin Nutr, 93, 652, 10.3945/ajcn.110.005538 · DOI · Paper page
- Rafraf, 2012, Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome, J Am Coll Nutr, 31, 361, 10.1080/07315724.2012.10720443 · DOI · Paper page
- Hurst, 2004, Effects of n-3 polyunsaturated fatty acids on COX-2 and PGE2 protein levels in articular cartilage chondrocytes, Int J Exp Pathol, 85, A22, 10.1111/j.0959-9673.2004.369ab.x · DOI
- Davidson, 2006, Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids, Am J Cardiol, 98, 27i, 10.1016/j.amjcard.2005.12.024 · DOI · Paper page
- Nestel, 2000, Fish oil and cardiovascular disease: Lipids and arterial function, Am J Clin Nutr, 71, 228S, 10.1093/ajcn/71.1.228S · DOI · Paper page
- Cussons, 2009, Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: A randomized controlled trial employing proton magnetic resonance spectroscopy, J Clin Endocrinol Metab, 94, 3842, 10.1210/jc.2009-0870 · DOI · Paper page
- Sadeghi, 2016, Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials, Diabetes Metab Syndr
- Mohammadi, 2012, Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome, Asia Pac J Clin Nutr, 21, 511
- Azziz, 2005, Diagnostic criteria for polycystic ovary syndrome: A reappraisal, Fertil Steril, 83, 1343, 10.1016/j.fertnstert.2005.01.085 · DOI · Paper page
- Vargas, 2011, Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome, Metabolism, 60, 1711, 10.1016/j.metabol.2011.04.007 · DOI · Paper page
- Hajianfar, 2011, The effect of omega-3 on the serum visfatin concentration in patients with type II diabetes, J Res Med Sci, 16, 490
- Nadjarzadeh, 2013, The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: A randomized clinical trial, Iran J Reprod Med, 11, 665
Cited by
Wang, T., Sha, L., Li, Y., Zhu, L., Wang, Z., Li, K., Lu, H., Bao, T., Guo, L., Zhang, X., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00284 · Cited by 162
“Omega-3 polyunsaturated fatty acids (PUFAs) were found to have new insights into health profit, such as anti-inflammatory, insulin sensitivity, cellular differentiation, and ovulation (35, 36).”
BackgroundThe Role of Lifestyle Interventions in PCOS Management: A Systematic Review
Gautam, R., Maan, P., Jyoti, A., Kumar, A., Malhotra, N., & Arora, T. (2025) · Nutrients · doi:10.3390/nu17020310 · Cited by 115
“Further, omega-3 fatty acid supplements in women with PCOS helped to improve biochemical parameters LH, LH/FSH, lipid profiles, WC, adiponectin levels, and regularized the menstrual cycle [125,126].”
Yang, K., Zeng, L., Bao, T., & Ge, J. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0346-x · Cited by 103
“The current study shows that metabolic disorders in patients with PCOS may be improved by the intervention of dietary factors such as anti-inflammatory foods [8].”
BackgroundMethodInfluentialXia, Y., Wang, Y., Cui, M., & Su, D. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1050 · Cited by 23
Dietary and serum n -3 PUFA and polycystic ovary syndrome: a matched case–control study
Lu, L., Li, X., Lv, L., Xu, Y., Wu, B., & Huang, C. (2022) · British Journal of Nutrition · doi:10.1017/s0007114521003007 · Cited by 20
“Two independent clinical studies have shown that daily oral supplementation with a certain amount of n -3 PUFA for 6 months significantly reduced waist circumference and BMI among PCOS patients (27,28) .”
Metadata
- Authors
- Khani, B., Mardanian, F., & Fesharaki, S. J.
- Venue
- Journal of Research in Medical Sciences
- Published
- 2017-01
- Volume
- 22
- Issue
- 1
- Pages
- 64-64
- ISSN
- 1735-1995 (ISSN-L)
- 1735-7136
- OpenAlex
- W2610335779
- Cited by
- 59
- References
- 3
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome. https://app.cochat.ai/papers/10.4103/jrms.jrms_644_16
- The paper
- Khani, B., Mardanian, F., & Fesharaki, S. J. (2017). Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome. Journal of Research in Medical Sciences. https://doi.org/10.4103/jrms.jrms_644_16
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.